PRECIGEN INC's ticker is PGEN and the CUSIP is 74017N105. A total of 139 filers reported holding PRECIGEN INC in Q3 2023. The put-call ratio across all filers is 0.23 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $19,529,510 | +51.0% | 13,753,176 | +22.3% | 1.15% | +59.4% |
| Q2 2023 | $12,930,093 | +733.3% | 11,243,560 | +668.1% | 0.72% | +4.1% |
| Q1 2023 | $1,551,586 | +27.9% | 1,463,760 | +83.4% | 0.69% | +17.3% |
| Q4 2022 | $1,213,264 | +92.0% | 798,200 | +167.7% | 0.59% | +87.0% |
| Q3 2022 | $632,000 | +58.0% | 298,200 | 0.0% | 0.32% | +78.0% |
| Q2 2022 | $400,000 | -74.7% | 298,200 | -60.1% | 0.18% | -66.9% |
| Q1 2022 | $1,579,000 | +42.8% | 748,200 | +150.9% | 0.54% | +67.7% |
| Q4 2021 | $1,106,000 | – | 298,200 | – | 0.32% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Patient Capital Management, LLC | 13,753,176 | $19,529,510 | 1.15% |
| IRIDIAN ASSET MANAGEMENT LLC/CT | 2,078,220 | $2,951,072 | 0.60% |
| EMFO, LLC | 425,000 | $603,500 | 0.57% |
| Opaleye Management Inc. | 928,500 | $1,318,470 | 0.43% |
| First Washington CORP | 646,575 | $918,137 | 0.37% |
| Fore Capital, LLC | 426,791 | $606,043 | 0.26% |
| SANDERS MORRIS HARRIS LLC | 410,000 | $582,200 | 0.12% |
| MSD Partners, L.P. | 960,000 | $1,363,200 | 0.11% |
| Virtus ETF Advisers LLC | 79,754 | $113,251 | 0.07% |
| CHIRON CAPITAL MANAGEMENT, LLC | 55,850 | $79,307 | 0.07% |